English Summary
Shenzhen Lifotronic Technology Co., Ltd. is a China Little Giant company report summary for overseas readers. The company is associated with Shenzhen. The report is indexed under Biomedicine and medical devices. The Chinese report was published on 2026-06-14. The summary covers company profile, product direction, industry-chain role, technology, patent/R&D signals, scale indicators and policy-material checkpoints.
Report Snapshot
| Company | Shenzhen Lifotronic Technology Co., Ltd. |
| Region | Shenzhen |
| Industry | Biomedicine and medical devices |
| Published | 2026-06-14 |
| Chinese report | Open |
Company and Recognition Snapshot
Shenzhen Lifotronic Technology Co., Ltd. is indexed as a national-level Little Giant enterprise in Shenzhen. The English profile places the company under Biomedicine and medical devices and records 2024 6th batch as the available recognition context.
| Recognition batch | 2024 6th batch |
| Region | Shenzhen |
| Industry | Biomedicine and medical devices |
| Registered capital | RMB 428.49 million |
| Employee signal | 426 employees |
| Listed status | Listed |
| Patent signal | 193 patent-related records |
| R&D signal | 2.2859 |
Business and Industry-chain Position
Chinese public records indicate medical-device or biomedicine activity, testing, inspection and technical-service activity, R&D, design and engineering activity. The recorded industry-chain position is Biomedicine and medical devices / Recorded position. This places the company in a policy-relevant segment for peer comparison by region, industry and batch.
Technology, Patent and R&D Signals
The public profile records 193 patent-related records. The R&D signal is: 2.2859. Patent and R&D information should be read with product direction, customer evidence and chain position rather than as isolated threshold items.
Policy-material Review Points
- Verify whether the company's main business, niche market and product evidence all point to Biomedicine and medical devices.
- Check that patent, R&D, employee and financial fields support the same core product direction.
- Compare the company with peers in the same province, industry and recognition batch before using the profile for supplier screening or policy research.
- Use the linked Chinese source report for original-language evidence and source links.
Original Report and Profile
For the underlying database record, open the English company profile. For full-length analysis, original-language wording and public evidence links, open the Chinese source report.